1. Broad and potent neutralizing human antibodies to tick-borne flaviviruses protect mice from disease
- Author
-
Jana Elsterová, Avery Peace, Anna Gazumyan, Filippo Bianchini, Pavel Svoboda, Yu E. Lee, Francesca Guidetti, Daniel Růžek, Marianna Agudelo, Anthony P. West, Tania Kapoor, Pamela J. Bjorkman, Václav Hönig, Kai-Hui Yao, Margaret R. MacDonald, Jennifer R. Keeffe, Dana Teislerova, Charles M. Rice, Melissa Cipolla, Thiago Y. Oliveira, Martin Palus, Davide F. Robbiani, Aleš Chrdle, Jiří Salát, and Michel C. Nussenzweig
- Subjects
0301 basic medicine ,medicine.drug_class ,030106 microbiology ,Immunology ,Cross Reactions ,Monoclonal antibody ,Antibodies, Viral ,Virus ,Epitope ,Article ,Encephalitis Viruses, Tick-Borne ,Cohort Studies ,Infectious Disease and Host Defense ,03 medical and health sciences ,Epitopes ,Omsk hemorrhagic fever ,Viral Envelope Proteins ,medicine ,Immunology and Allergy ,Animals ,Humans ,Amino Acid Sequence ,Neutralizing antibody ,Cells, Cultured ,Mice, Inbred BALB C ,biology ,Sequence Homology, Amino Acid ,Antibodies, Monoclonal ,medicine.disease ,Virology ,Antibodies, Neutralizing ,Survival Analysis ,030104 developmental biology ,Immunoglobulin G ,biology.protein ,Female ,Antibody ,Kyasanur forest disease ,Encephalitis, Tick-Borne ,Louping ill - Abstract
Agudelo et al. discover expanded clones of similar antibodies from the memory B cells of tick-borne encephalitis virus–infected and vaccinated donors; however, the most potent and broadly neutralizing antibodies derive from donors recovering from natural infection., Tick-borne encephalitis virus (TBEV) is an emerging human pathogen that causes potentially fatal disease with no specific treatment. Mouse monoclonal antibodies are protective against TBEV, but little is known about the human antibody response to infection. Here, we report on the human neutralizing antibody response to TBEV in a cohort of infected and vaccinated individuals. Expanded clones of memory B cells expressed closely related anti-envelope domain III (EDIII) antibodies in both groups of volunteers. However, the most potent neutralizing antibodies, with IC50s below 1 ng/ml, were found only in individuals who recovered from natural infection. These antibodies also neutralized other tick-borne flaviviruses, including Langat, louping ill, Omsk hemorrhagic fever, Kyasanur forest disease, and Powassan viruses. Structural analysis revealed a conserved epitope near the lateral ridge of EDIII adjoining the EDI–EDIII hinge region. Prophylactic or early therapeutic antibody administration was effective at low doses in mice that were lethally infected with TBEV.
- Published
- 2021